Financial News

Financial Report: PAREXEL

Achieves record new business wins in the quarter

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Financial Report: PAREXEL   4Q Revenues: $538.6 million (+3%)   4Q Earnings: $44.3 million (+30%)   FY Revenues: $2.1 billion (+4%) FY Earnings: $156.5 million (+6%) Comments: Backlog as of June 30, 2016 was $5.7 billion, an increase of approximately $400 million year over year. Backlog included gross new business wins in the quarter of $967 million, cancellations of $322 million, and a negative impact from foreign currency exchange rates of $37 million. The net book-to-bill ratio w...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters